RxDoctor Payments Data

Kristine Kingery, PA

Physician Assistant · Middleton, IDNPI 1679517155

Payments from drug & device makers

$1,305in general payments, 2019–2025

Across 66 payments — averaging $19.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$226
  • Novo Nordisk$177
  • Lilly USA, LLC$111
  • AbbVie$94
  • Exact Sciences$87
  • AstraZeneca$78
  • plus $531 from 17 others

What the payments were for

  • Food & beverage$1,16589%
  • Education$14011%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,305 in reported general payments places this provider in the 75th percentile of 1,027 physician assistant providers in Idaho.

See all physician assistant providers in Idaho

Medicare billing

Part B allowed, 2024
$38,581
Medicare patients
158
Services billed
729

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide47$56,072
RybelsusSemaglutide29$33,527
OzempicSemaglutide34$32,303
FarxigaDapagliflozin Propanediol49$32,211
Trelegy ElliptaFluticasone/Umeclidin/Vilanter44$32,123
EliquisApixaban24$24,166
TrulicityDulaglutide15$17,925
JardianceEmpagliflozin13$15,053
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog27$13,950
Spiriva HandihalerTiotropium Bromide16$10,818
Combivent RespimatIpratropium/Albuterol Sulfate12$7,468
SymbicortBudesonide/Formoterol Fumarate14$5,528
Albuterol Sulfate HfaAlbuterol Sulfate135$4,085
Fluticasone-SalmeterolFluticasone Propion/Salmeterol32$3,903
Levothyroxine Sodium273$3,383

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$111$73,99662 claims
Novo NordiskRybelsus, Ozempic$177$65,83063 claims
AstraZenecaFarxiga, Symbicort$78$37,73963 claims
GSKTrelegy Ellipta$73$32,12344 claims
PfizerEliquis$33$24,16624 claims
AbbVieSynthroid$94$1,89115 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,027 physician assistant providers in Idaho.

Other physician assistant in Middleton

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →